chartexchange

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 5, 2026 4:01 PM EST

Preparing for anticipated bezuclastinib launch in  GIST; PDUFA action date November 30, 2026 NonAdvSM PDUFA target action date December 30, 2026; AdvSM PDUFA target action date June 29, 2027

Read original article